D&D Pharmatech (347850) drew market attention on the 16th as a static Volatility Control Mechanism (VI) was triggered due to a sharp surge in its stock price during the afternoon session.

According to the Korea Exchange, the static VI for D&D Pharmatech was activated at 1:55:18 p.m. on the same day. The trigger price was 91,600 won, representing a disparity rate of 10.09% compared to the base price (83,200 won). The activation of the static VI is interpreted as a result of strong buying pressure flowing into the stock, causing the price to soar in a short period of time.

The Volatility Control Mechanism (VI) is a system that applies single-price trading for a certain period to stabilize the market and protect investors when the price of an individual stock experiences sharp fluctuations in a short time. In particular, the static VI is triggered when the stock price moves beyond a certain threshold compared to the most recent single price or the base price. After the VI is triggered, single-price trading is conducted for a set period before returning to normal trading.

The market analyzes that as investment sentiment in the overall biotech sector has recently improved, stock price volatility driven by changes in supply and demand for individual stocks has been increasing. In particular, expectations for new drug development, clinical trial progress, and technology transfers are cited as key factors influencing investment sentiment in biotech stocks.

Experts advise that investors should be mindful of the sharp price volatility that may occur during the process of trading resumption following a VI activation. They also urged investors to closely monitor future supply and demand trends as well as changes in trading volume.

[※ This article was written with the assistance of artificial intelligence (AI) analysis tools, and the final content is provided after an editorial process. The content included in this article is for informational purposes only and does not constitute a recommendation to buy or sell any specific stock or financial product. Investment decisions and the resulting responsibilities lie entirely with the investor. Actual results may vary depending on market conditions.]